Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and Warfarin

University of Pennsylvania1,971 enrolled

Overview

To determine if a computerized stop order will reduce the number of concurrent trimethoprim/sulfamethoxazole and warfarin orders accepted through the inpatient electronic ordering system while a patient is hospitalized.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

SINGLE

Enrollment

1,971

Conditions

Prescribers' Drug Orders

Interventions

Trimethoprim/Sulfamethoxazole and WarfarinDRUG

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: All resident physicians and nurse practitioners involved in inpatient care. Exclusion Criteria: None-

Outcomes

Primary Outcomes

Reduce concomitant orders for warfarin and tmp/smx

Time frame: 7 months

Secondary Outcomes

Determine if computerized stop order will increase risk for inadvertent cessation of warfarin

Time frame: 7 months

Determine if computerized stop order will increase risk of delay of treatment with tmp/sulfa when determined to be necessary for treatment

Time frame: 7 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.